volume 40, issue 5, P466-472 2018
DOI: 10.1093/eurheartj/ehy424
View full text
|
|
Share

Abstract: In this multicentre trial, the Cardioband mitral system demonstrated reasonable performance and safety. At 1 year, most patients had moderate or less MR and experienced significant functional improvements. A randomized controlled trial is underway to demonstrate the impact of Cardioband in patients on guideline-directed medical therapy.